Cargando…
Sentinel lymph node biopsy in high-risk endometrial cancer: performance, outcomes, and future avenues
Endometrial cancer is the second most common gynecological malignancy worldwide, with an overall favorable prognosis. However, a subgroup of patients has a high risk of recurrence and poor prognosis. This review summarizes recently published articles that examined sentinel lymph node (SLN) biopsy in...
Autores principales: | Kim, Yoo-Na, Kim, Young Tae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Obstetrics and Gynecology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483671/ https://www.ncbi.nlm.nih.gov/pubmed/35916013 http://dx.doi.org/10.5468/ogs.22146 |
Ejemplares similares
-
Performance of sentinel lymph node biopsy in high-risk endometrial cancer
por: Ehrisman, Jessie, et al.
Publicado: (2016) -
Status of Sentinel Lymph Node Biopsy in Endometrial Cancer
por: Taran, Florin Andrei, et al.
Publicado: (2021) -
Sentinel lymph node biopsy in endometrial cancer: state of the art
por: Della Corte, Luigi, et al.
Publicado: (2020) -
Applications and Safety of Sentinel Lymph Node Biopsy in Endometrial Cancer
por: Chiu, Wan Kam, et al.
Publicado: (2022) -
Update on Sentinel Lymph Node Biopsy in Surgical Staging of Endometrial Carcinoma
por: Eriksson, Ane Gerda Z, et al.
Publicado: (2021)